CapsoVision, Inc. (CV) vs Turn Therapeutics Inc. (TTRX)
A side-by-side comparison of CapsoVision, Inc. and Turn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CV
CapsoVision, Inc.
$6.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TTRX
Turn Therapeutics Inc.
$11.64HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CV vs TTRX
growth of $100 · dividends reinvested · last 1yCV +43.3% (+43.3%/yr)TTRX +76.6% (+76.6%/yr)TTRX compounded faster over this window
CV TTRX
CV vs TTRX: by the numbers
- •TTRX is the larger company ($347M vs $325M market cap).
- •Both run net losses; TTRX's is the smaller (0.00% vs -214.74% net margin).
Metrics side by side
Valuation
| Metric | CV | TTRX |
|---|---|---|
| P/S ratio | 23.38 | N/A |
| P/B ratio | 24.67 | 504.79 |
Profitability
| Metric | CV | TTRX |
|---|---|---|
| Gross margin | 50.88% | 0.00% |
| Operating margin | -188.25% | 0.00% |
| Net margin | -214.74% | 0.00% |
| ROE | -226.56% | -1229.58% |
| ROIC | -164.32% | -84.66% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.